Improving Prescription Drug Affordability Through Regulatory Action

被引：4
作者：
Bush, Laina [1 ]
Sommers, Benjamin D. [1 ]
机构：
[1] US Dept HHS, Off Assistant Secretary Planning & Evaluat, 200 Independence Ave SW, Washington, DC 20201 USA
来源：
JAMA HEALTH FORUM | 2022年 / 3卷 / 08期
关键词：
D O I：
10.1001/jamahealthforum.2022.3180
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 5 条
  • [1] Projected US Savings From Biosimilars, 2021-2025
    Mulcahy, Andrew
    Buttorff, Christine
    Finegold, Kenneth
    El-Kilani, Zeid
    Oliver, Jon F.
    Murphy, Stephen
    Jessup, Amber
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2022, 28 (07) : 329 - +
  • [2] Mulcahy AW, International prescription drug price com- parisons.
  • [3] Office of the Assistant Secretary for Planning and Evaluation US Department of Health and Human Services, COMPR PLAN ADDR HIGH
  • [4] Tarazi W, PRESCRIPTION DRUG AF
  • [5] US Department of Health and Human Services Centers for Medicare & Medicaid Services, 2022, MED PROGR CONT YEAR
1